Literature DB >> 11299774

Low density lipoprotein receptor and mRNA expression in human colorectal cancer.

M G Caruso1, M Notarnicola, A Cavallini, A Di Leo.   

Abstract

BACKGROUND: We have previously show that, 63.3% of colorectal cancers did not express the Low Density Lipoprotein Receptor (LDLR). We now report the findings of a study on the expression of LDLR and its mRNA in neoplastic tissue specimens of human colorectal cancer (CRC), carried out to verify whether the absence of the LDLR in these tumours is reflected by the absence of its transcript.
MATERIALS AND METHODS: 32 patients (10 females and 22 males) operated for CRC were included in the study. The LDLR levels were evaluated by immunoenzymatic assay. The LDLR-mRNA, reverse-transcribed and then amplified by polymerase chain reaction, was detected by chromatography.
RESULTS: The LDLR protein was present in 12 out of the 32 patients. LDLR-mRNA expression was detected in 17 out of the 32 patients. The absence of the LDLR protein was reflected by the absence of its transcript in 13 out of the 20 tumours; The LDLR mRNA levels were significantly higher in the tumours that did not expres LDLR.
CONCLUSION: The variable expression of the LDLR protein and LDLR mRNA in CRC detected in this study suggests the possibility that different therapeutic strategies may be indicated for these tumours.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299774

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Ian R Corbin; Hui Li; Juan Chen; Sissel Lund-Katz; Rong Zhou; Jerry D Glickson; Gang Zheng
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

Review 2.  Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason.

Authors:  Jaideep Chaudhary; Joseph Bower; Ian R Corbin
Journal:  Int J Mol Sci       Date:  2019-12-15       Impact factor: 5.923

3.  Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment.

Authors:  Liping Song; Hui Li; Ulas Sunar; Juan Chen; Ian Corbin; Arjun G Yodh; Gang Zheng
Journal:  Int J Nanomedicine       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.